SELECT-AML-1: Phase 2 Randomized Trial of Tamibarotene in Combination With Venetoclax and Azacitidine in Adult Patients With Previously Untreated AML With RARA Overexpression, Who Are Ineligible for Standard Induction Therapy

Autor: Borate, Uma, McMahon, Christine, Fenaux, Pierre, Heiblig, Mael, Peterlin, Pierre, Ball, Brian, Chantepie, Sylvain, Eghtedar, Alireza, Kambhampati, Suman, Solh, Melhem, Torregrosa-Diaz, Jose, Braun, Thorsten, de Botton, Stephan, Dugan, James, Feld, Jonathan, Gourin, Marie-Pierre, Pigneux, Arnaud, Robin, Jean-Baptiste, Schiller, Gary, Stein, Eytan, Roth, David, Baker, Kristen, Paul, Sofia, Kelly, Michael, Pollyea, Daniel, Cluzeau, Thomas
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S170-S170
Databáze: ScienceDirect
Externí odkaz: